Xlife Sciences AG
A life sciences incubator commercializing early-stage academic research for healthcare markets.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Xlife Sciences AG is a Swiss company that operates as a life sciences incubator and accelerator. It focuses on the value development and commercialization of promising, early-stage research projects sourced from universities and other research institutions. The company's mission is to bridge the gap between academic research and healthcare markets by advancing solutions for high unmet medical needs. Xlife Sciences concentrates its investments and development efforts across four key pillars: technology platforms, biotechnologies/therapies, medical technology (healthtech), and the application of artificial intelligence in digital health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-01 07:00 |
Regulatory Filings
Xlife Sciences AG Delivers Breakthrough in Early Alzheimers Detection, Unlockin…
|
English | 3.7 KB | ||
| 2025-12-01 01:00 |
Regulatory Filings
Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocki…
|
English | 5.8 KB | ||
| 2025-12-01 01:00 |
Regulatory Filings
Xlife Sciences AG erzielt Durchbruch bei der Früherkennung von Alzheimer und er…
|
German | 9.0 KB | ||
| 2025-11-28 13:10 |
Regulatory Filings
Xlife Sciences AG Provides Update on VERAXA Biotech AGs NASDAQ Listing Process …
|
English | 9.0 KB | ||
| 2025-11-28 01:00 |
M&A Activity
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process…
|
English | 11.7 KB | ||
| 2025-11-28 01:00 |
Regulatory Filings
Xlife Sciences AG gibt ein Update zum Stand des NASDAQ-Listing-Prozesses der VE…
|
German | 12.0 KB | ||
| 2025-10-16 07:00 |
Environmental & Social Information
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | 8.0 KB | ||
| 2025-10-16 02:00 |
Environmental & Social Information
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a St…
|
English | 10.2 KB | ||
| 2025-10-16 02:00 |
Environmental & Social Information
Xlife Sciences AG veröffentlicht ESG-Bericht 2024: Nachhaltige Wertschöpfung al…
|
German | 9.8 KB | ||
| 2025-09-23 07:00 |
Report Publication Announcement
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AGs NASDAQ Lis…
|
English | 7.0 KB | ||
| 2025-09-23 02:00 |
Earnings Release
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Li…
|
English | 9.5 KB | ||
| 2025-09-23 02:00 |
Earnings Release
Xlife Sciences AG Halbjahresbericht 2025: Fokus auf NASDAQ-Listing der VERAXA B…
|
German | 13.3 KB | ||
| 2025-07-17 07:00 |
Registration Form
Xlife Sciences AGs Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward …
|
English | 12.6 KB | ||
| 2025-07-17 02:00 |
M&A Activity
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward…
|
English | 15.5 KB | ||
| 2025-07-17 02:00 |
Registration Form
Portfoliounternehmen der Xlife Sciences AG, VERAXA Biotech AG, erreicht wichtig…
|
German | 16.4 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
